FDA Authorizes Pfizer Booster COVID Shot for Children Between the Ages of 5 and 11

Today (May 17, 2022), the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) and authorized a booster dose of the Pfizer-BioNTech COVID-19 shot for children 5 through 11 years of age. The booster shot is 10 micrograms, which is the same dosage for this age group in their primary series and a third of that given to people aged 12 and older.

The decision will now go to the Centers for Disease Control and Prevention (CDC) for approval.

On April 28, 2022, Moderna submitted a request to the FDA for EUA for its two-dose COVID-19 injection for children ages six months to under six years old.

When it comes to COVID, public health officials have consistently downplayed and ignored natural immunity among children. Yet 81 research studies confirm that natural immunity to COVID is equal or superior to any “vaccine immunity.”

Research shows that there is no benefit to children receiving a COVID shot, and in fact, the shots can cause potential harm, adverse effects and death. According to Pfizer’s own study trial data, the chance of death in children from the shot is 107 times higher than death from COVID.

In fact, the CDC recently reported higher COVID-19 case rates have been recorded among fully vaccinated children than unvaccinated in the age group 5-11 since February 2022. That’s the first time CDC recorded a higher case rate among fully vaccinated young children since data was first collected in December 2021.

In addition, the Office for National Statistics revealed that children are up to 52 times more likely to die following the COVID-19 injection than children who have not received it. In December 2021, the Office for National Statistics (ONS) published a dataset containing details on “deaths by vaccination status in England” per 100,000 people between January 1, 2021 and Oct 31, 2021. The data revealed that vaccinated children aged 10-14 were statistically 10 times more likely to die than unvaccinated children, and vaccinated teenagers aged 15-19 were statistically two times more likely to die than unvaccinated teenagers.

However, the ONS data also shows during that time period, teenagers aged 15-19 who had two COVID shots were statistically three times more likely to die than teenagers who were not vaccinated. Children aged 10-14 who were double vaccinated were statistically 52 times more likely to die than unvaccinated children.

Scientific studies show that children are at very low risk of spreading the COVID infection to other children, to adults as seen in household transmission studies, or becoming very ill or dying. According to a 2020 Yale University report, scientists have observed that children fare much better than adults and have very diverse and different immune system responses to SARS-CoV-2 infection and have far less illness or mortality from COVID. Studies by Ankit B. Patel and Dr. Supinda Bunyavanich show the virus has limited expression and presence in the upper respiratory area in young children. This partly explains why children are less likely to be infected in the first place, or spread it to other children or adults, or even get severely ill. Research published in August 2021 by J. Loske also revealed that “the airway immune cells in children are primed for virus sensing resulting in a stronger early innate antiviral response to SARS-CoV-2 infection than in adults.”

 

Source: https://healthimpactnews.com/2022/fda-authorizes-pfizer-booster-covid-shot-for-children-between-the-ages-of-5-and-11/

Liberty Counsel

One thought on “FDA Authorizes Pfizer Booster COVID Shot for Children Between the Ages of 5 and 11

Leave a Reply

Your email address will not be published.